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Abstract 
Previous studies from our laboratory have shown that under blood bank storage conditions red blood cell (RBC) ATP 
and lipid content were better maintained in a glycerol-containing hypotonic experimental dditive solution (EAS 25) than in 
the conventional storage medium Adsol ®. The objective of this study was to determine the mechanism of the protective 
effect of EAS 25, by measuring transmembrane phospholipid asymmetry and the membrane integrity of stored RBCs. Split 
units of packed RBCs were stored in either EAS 25 or Adsol ®. RBCs were analyzed after 0, 42, and 84 days and vesicles 
shed from stored RBCs were analyzed after 84 days of storage. Phospholipid asymmetry was measured by phospholipase 
A 2 digestion (RBCs) and activation of the prothrombinase complex (RBCs, vesicles). RBC membrane xhibited a 
significantly greater (P  < 0.01) amount of phosphatidylethanolamine ext rnalized after storage in Adsol ® than in EAS 25 
(44.3%, + 11.7 vs. 25.3% + 5.7, respectively). Prothrombin converting activities in RBCs were significantly lower than in 
shed vesicles (P  < 0.001) suggesting the presence of phosphatidylserine i  the outer monolayer of vesicle, but not in RBC 
membranes. The rates of inwardly-directed aminophospholipid transport in RBCs decreased by ~ 50% and glutathione 
levels decreased by ~ 50% in both media. RBC cholesterol and phospholipid content of stored RBCs remained 
significantly greater (P < 0.01) in EAS 25 than in Adsol®. The results indicate that despite comparable r duction in the rate 
of aminophospholipid transport and reduced GSH concentrations, RBC phospholipid asymmetry was better maintained 
during storage in EAS 25 than in Adsol ®. The data suggest hat glycerol in the hypotonic EAS helps preserve RBC lipid 
organization and membrane integrity during storage. © 1997 Elsevier Science B.V. 
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1. Introduction 
In normal red blood cells (RBCs) phospholipids 
are asymmetrically distributed across the membrane 
bilayer. Choline-containing phospholipids, phos- 
phatidylcholine and sphingomyelin, are enriched in 
the outer leaflet and the aminophospholipids, phos- 
phatidylethanolamine (PE) and phosphatidylserine 
(PS), are concentrated in the inner leaflet of the lipid 
bilayer [1-4]. Maintenance of this non-random distri- 
bution of phospholipid has been attributed to the 
action of an aminophospholipid-specific, ATP-depen- 
dent aminophospholipid translocase [5-10], the inter- 
action of phosphatidylserine with cytoskeletal pro- 
teins [11-14], and the inherently slow passive trans- 
bilayer movement of phospholipids [15,16]. Disrup- 
tion of the normal asymmetric lipid distribution re- 
sults in altered biophysical properties of the erythro- 
cyte membrane including changes in membrane fluid- 
ity, lipid packing, and cell surface charge [17-22]. 
Macrophages recognize these perturbations and en- 
hanced phagocytosis ensues [23-27]. Aging and oxi- 
dant damage are also known to perturb the membrane 
and enhance phagocytosis [22,23]. It is, therefore, 
important to understand and prevent these changes to 
improve the quality of stored blood. 
Studies from our laboratory and others have 
demonstrated that under blood bank storage condi- 
tions RBCs lose ATP, have altered transmembrane 
phosphatidylethanolamine asymmetry, and shed band 
3- and band 4.1-enriched microvesicles [28-36]. The 
molecular mechanisms responsible for RBC vesicula- 
tion are still controversial. Loss of phospholipid 
asymmetry, disruption of membrane skeleton, and 
calpain-mediated degradation of cytoskeletal protein 
are some of the factors associated with the vesicula- 
tion process [37-41]. It is likely that long term 
storage alters one or more of these mechanisms, 
resulting in a loss of lipid asymmetry, since lipid 
scrambling has been associated with vesiculation, 
either by cause [8,42-44] or effect [45-47]. 
In contrast, storage in a hypotonic experimental 
additive solution (EAS) containing 10-50% ammo- 
nium chloride and 10-40% phosphate (P~) in addition 
to adenine, glucose, mannitol and sodium chloride, 
partially preserved RBC ATP levels, improved in 
vivo survival and reduced storage mediated changes 
[48,49]. However, the substitution of glycerol (0.69% 
final concentration) for ammonium chloride in the 
RBC preservation medium (EAS 25) better maintains 
ATP levels and the content of protein bands 3 and 4.1 
when compared with the conventional storage 
medium, Adsol c"~. Traditionally, glycerol at a final 
concentration f 20-40%, is used for preservation of
frozen RBCs. The rationale for substituting lycerol 
in place of ammonium chloride is because it is 
pharmacologically inert and permeates membranes 
freely. The concentration of glycerol in EAS 25 
(0.69%) is within the amount permitted in previously 
frozen, deglycerolized RBCs and allows the preserva- 
tion of RBCs in a liquid, rather than frozen, state 
[50]. 
We hypothesized that compared to Adsol ~R~, EAS 
25 conserves phospholipid asymmetry and thus, the 
membrane and cellular integrity of the stored human 
RBCs. The present results show that despite compa- 
rable reduction in the rate of phosphatidylserine 
transport and reduced glutathione (GSH) concentra- 
tion during storage in both media, RBC transmem- 
brane phospholipid asymmetry was better maintained 
in EAS 25 than in Adsol ®. These data suggest hat 
glycerol in the hypotonic EAS protects membrane 
integrity. 
2. Materials and methods 
2.1. Samples 
Blood donors acceptable by the American Associa- 
tion of Blood Banks and Food and Drug Administra- 
tion criteria were used. The protocol was approved by 
the University of Cincinnati's Institutional Review 
board. Standard units of blood (450 _+ 45 mL) were 
collected into polyvinyl chloride (PVC) bags (PL 
146, Baxter Healthcare Corporation, Deerfield, IL) 
containing 63 mL citrate-phosphate-dextrose (CPD) 
anticoagulant and were centrifuged (RC-3B, Sorval, 
Dupont, Wilmington, DE) for 10 min at 835 × g. The 
platelet-rich plasma was expressed into a satellite 
bag. The packed RBCs were divided into two aliquots 
by weight in 300 mL PVC transfer bags (code 
4R2001, Fenwal Laboratories, Deerfield, IL), using a 
sterile connection device (SCD 312, Haemonetics, 
Braintree, MA). One aliquot was stored with 100 mL 
Adsol®/unit and the other aliquot was stored in an 
equal volume of EAS 25 (prepared as previously 
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Table l 
Composition of additive solutions (mM) 
Adsol ~ EAS 25 
Adenine 2 2 
Dextrose 122 110 
Mannitol 42 55 
Glycerol - 150 
NaC1 154 50 
pH at 25°C 5.86 7.15 
Milliosmolality (mosmol/kg) 
total 475 406 
nonpenetrating ~ 322 145 
*' Nonpenetrating milliosmolality represents components which 
do not penetrate the cell. 
described [35]). The composition of the additive solu- 
tions are shown in Table 1. All units were stored at 
1-6°C and thoroughly mixed (10 min) on a platelet 
agitator (Meddev Corporation, Los Altos, CA) before 
sampling at 0, 28, 42, and 84 days of storage. Steril- 
ity was confirmed by inoculating 1.0 mL of the final 
sample into tubes of thioglycolate and tryptic soy 
broth. 
2.2. Preparation of erythrocytes and microvesicles 
RBCs were isolated from the stored blood samples 
by centrifugation for 10 min at 2000 X g and washed 
three times in phosphate-buffered saline (PBS: 138 
mM NaC1, 5 mM KC1, 6.1 mM Na2HPO4, 1 mM 
MgC12, pH 7.4), stored on ice, and processed within 
24 h for phospholipase treatments, measurement of
prothrombinase converting activity, lipid analysis, and 
lipid transport assays. 
Microvesicles were isolated as previously de- 
scribed [35]. Briefly, the supernatant was collected 
after centrifugation for 10 min at 2000 x g and passed 
through 0.8 /~m nitrocellulose filters (Nuclepore Cor- 
poration, Pleasanton, CA) in a commercial filtration 
system at 5-10 lbs/ in 2 N 2 pressure. The filtered 
supernatants were centrifuged for one hour at 38 000 
× g and the isolated vesicle pellet was washed and 
suspended in PBS containing 2 mM EDTA and l 
mM phenylmethylsulfonyl fluoride. 
2.3. Euthrocyte and vesicle membrane lipid determi- 
nation 
Lipid extraction and analysis of phospholipids and 
cholesterol were performed as previously described 
[35]. Cholesterol and phospholipid concentrations 
were expressed as /zmol /mL RBC and molar frac- 
tions of cholesterol/phospholipid were calculated. 
2.4. Phospholipase treatments 
Transmembrane phospholipid asymmetry was de- 
termined by phospholipase digestion of outer mono- 
layer phospholipids following a modification [36] of 
the method of Wilson et al. [51]. This procedure of 
outer monolayer digestion has been shown to produce 
< 3% hemolysis, 50_+ 5% hydrolysis of the total 
phospholipid pool, and produce no net shape change 
[36]. These requirements were met by > 93% of the 
samples analyzed; samples not meeting these criteria 
were discarded. 
2.5. Phospholipid analysis 
Erythrocytes treated with phospholipase A2s  were  
lysed in Tris buffer (10 mM Tris base, 2 mM EDTA, 
pH 7.4), and the membranes were collected by cen- 
trifugation (10 min at 16000 × g). This procedure 
was repeated 4-6 times until the supernatant was 
clear. Phospholipids were extracted by a modification 
of the procedure of Comfurius and Zwaal [52], with 
the addition of two chloroform washes of the aqueous 
phase. The combined organic phases were dried un- 
der a stream of nitrogen and reconstituted in 20 /xL 
of chloroform/methanol (4:1, v/v).  Lipids were sep- 
arated by two-dimensional thin-layer chromatography 
[51] and quantified by phosphate analysis [53] of 
spots scraped from each plate. 
2.6. Prothrombin converting acti~,i b, 
Erythrocyte prothrombin converting activity was 
assayed according to Wilson et al. [51]. Released 
thrombin was measured using the chromogenic sub- 
strate sarcosine-pro-arg-p-nitroanilide (500 /xM final 
concentration) [54]. 
2.7. Phosphatidylserine transport 
Phosphatidylserine transport was measured using 
short chain phospholipids and the cell morphological 
method of Daleke and Huestis [6,7]. Briefly, cells 
were treated with sonicated vesicles composed of 
dilauroylphosphatidylserine (DLPS). At appropriate 
268 U.J. Dumaswala et al. / Biochimica et Biophysica Acta 1330 (1997) 265-273 
time intervals, aliquots of the cell suspension were 
fixed in 10 volumes of buffered glutaraldehyde (0.5%) 
and viewed by light microscopy. Cell shape was 
scored according to a morphological index scale [7]: 
discocytes were scored 0, echinocytes were given 
positive values depending on degree of spiculation, 
and stomatocytes were given negative values depend- 
ing on the degree of invagination. The average score 
of a field of 100 cells was defined as the Morphologi- 
cal Index (MI). Rates of lipid transport were derived 
from this data by calculating rate of change in MI 
(AMI /min)  after the initial incorporation of exoge- 
nous lipid (~ 5 min) [7]. The Morphological Index 
scale is linear with respect o lipid incorporation in 
this range [7], allowing a comparison of relative 
transport rates. 
2.8. Miscellaneous assays 
Protein assays were performed using the method of 
Bradford [55]. Since vesicle membranes contain 
hemoglobin, a correction was made for hemoglobin 
content [56]. ATP measurements were performed as 
previously described [35]. Glutathione was measured 
by the reduction of 5,5'-dithiobis(2-nitrobenzoic ac d) 
as described by Beutler [57]. 
3. Results 
3.1. Effect of storage media on lipid composition and 
vesiculation 
Compared to prestored (fresh) cells, erythrocytes 
lose a significantly (P  < 0.01) greater amount of 
cholesterol and phospholipids during storage in Ad- 
sol ® than in EAS 25 (Fig. 1). RBC lipid loss during 
storage can be attributed to vesiculation. Analysis of 
vesicular cholesterol and phospholipid content sug- 
gests that the degree of vesiculation was proportional 
to the RBC lipid loss. The C /P  ratios were not 
significantly different for RBCs or vesicles in either 
media, but the cholesterol and phospholipid content 
of the vesicles shed by RBCs stored in EAS 25 was 
significantly lower compared to those in Adsol ® 
(P  < 0.001) (Figs. 1 and 2). RBCs stored in EAS 25 
shed significantly less vesicular membrane proteins 
(P  < 0.002) than those stored in Adsol ® (Fig. 2). 
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Fig. 1. Erythrocyte cholesterol (C), phospholipid (P) and molar 
cholesterol:phospholipid ratios (C /P )  after storage in Adsol ® 
and EAS 25 for 42 days (A) or 84 days (B). Cholesterol and 
phospholipid were measured as described in Section 2. Data are 
expressed as means_+ S.D. ( /xmol /mL RBC); n = 9; * P < 0.01 
(we-storage vs. AdsoI®/EAS 25); * P < 0.01 (Adsol ® vs. EAS 
25). 
3.2. Phospholipid asymmetry and aminophospholipid 
transport 
RBCs stored for 42 days in Adsol ® expressed 
significantly greater amounts of PE in the outer leaflet 
compared to those stored in EAS 25 (P  < 0.001), as 
assayed by phospholipase accessibility (Fig. 3). The 
accessibility of other phospholipids to exogenous 
phospholipases was not affected significantly. Ery- 
throcyte prothrombin converting activity of RBC 
membranes was similar in both media (Table 2), 
supporting a lack of externalization of PS. In con- 
trast, prothrombin converting activity of the vesicular 
membranes was significantly greater than RBCs indi- 
cating at least a partial loss of PS asymmetry in 
vesicular membranes. One of the mechanisms postu- 
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Fig. 2. Vesicle membrane cholesterol (C), phospholipid (P), 
cholesterol:phospholipid ratios (C/P) and total protein after 84 
days storage in Adsol ® and EAS 25. Cholesterol, phospholipid, 
and total protein content were measured as described in Section 
2. Data are expressed as means + S.D. (lipids: kLmol/mL RBC; 
protein: mg/mL RBCs); n = 14; * P < 0.001 (Adsol ® vs. EAS 
25). 
lated for maintaining aminophospholipid asymmetry 
is via an ATP-dependent flippase [5-7]. We observed 
that after 42 days of storage, the initial rate of DLPS 
transport decreased ~ 50% in both groups 
(AMI/min =-0 .06)  compared to fresh samples 
(AMI/min = --0.11; Fig. 4). In addition, the mor- 
phological index achieved after 60 min in the control 
cells was slightly less then that in the stored cells. To 
determine the equilibrium value of the morphological 
index, the data describing the transport phase (> 5 
min) were fit to a first-order kinetic equation. This 
analysis indicated that cells stored in EAS 25 dis- 
played a 1% increase in equi l ibr ium morphological  
index, whi le those stored in Adsol  showed a 9% 
increase, compared with control cells. These data 
indicate that the equi l ibr ium t ransmembrane asym- 
Table 2 
Prothrombin converting activity of erythrocytes and shed vesicles 
after 84 days of storage "
Pre EAS 25 Adsol ® 
Erythrocytes 6.24 + 0.2 4.74 + 1.6 6.48 + 0.9 
Vesicles * - 13.1___8.2 11.4+3.2 
Released thrombin was measured using the chromogenic sub- 
strate sarcosine-pro-arg-p-nitroanilide (500 /zM final concentra- 
tion) [44]. 
Results are expressed as nM thrombin produced per min per/xg 
phospholipid. Data are expressed as means + S.D.; n = 3 or 4. 
* P _< 0.05 (vesicles vs. erythrocytes). 
Fig. 3. Outer monolayer phospholipid composition of erythro- 
cytes stored for 42 days in the indicated additive as determined 
by phospholipase hydrolysis. Samples were assayed as described 
in Section 2. Data are expressed as means+S.D. (%); n =6; 
* P < 0.01 (Adsol ® vs. pre-storage or EAS 25). 
metric distribution of DLPS was only slightly less 
pronounced in the stored cells. 
3.3. RBC ATP and glutathione 
RBC ATP levels declined during storage; however 
this decline was significantly greater in Adsol ® than 
in EAS 25 after 84 days of storage (P < 0.01; Table 
3). Interestingly, RBC ATP values were similar in 
both media after 42 days of storage (2.34 _+ 0.67 
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Fig. 4. Aminophospholipid transport activity in erythrocytes 
stored for 42 days. Erythrocytes were stored in the indicated 
additives as described in Section 2. Following storage, erythro- 
cytes were washed and incubated with DLPS liposomes (250 
/xM). At the indicated time points, an aliquot of RBCs was fixed 
in glutaraldehyde, xamined by light microscopy and a Morpho- 
logical Index (MI) was calculated. 
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Fig. 5. Erythrocyte reduced glutathione content after storage in 
Adsol ® and EAS 25. GSH was measured as described in Section 
2. Data are expressed as means +_ S.D. (mg/dL  of RBC); n = 5; 
* P < 0.01 (pre-storage vs. AdsoI®/EAS 25). 
/xmol/g Hb and 2.41 _+ 0.56/zmol/g Hb for Adsol ® 
and EAS 25, respectively). Erythrocyte glutathione 
content decreased by ~ 50% after 84 days of storage 
in both groups (Fig. 5). 
4. Discussion 
The specific aim of the current study was to 
identify storage-induced lesions in erythrocyte mem- 
branes and to gain an insight into mechanisms in- 
volved in the preservation of RBC membrane lipid 
asymmetry during storage. These results indicate that 
storage of human RBCs in a glycerol-containing hy- 
potonic additive prevents flipping of PE from the 
inner- to the outer-leaflet of the membrane. 
Several studies have shown that an ATP-dependent 
aminophospholipid translocase contributes signifi- 
cantly to the maintenance of PS and PE transmem- 
brane asymmetry [5-9]. Loss of translocase activity 
may contribute to a loss of lipid asymmetry during 
storage. Geldwerth et al. [58] reported a progressive 
loss of translocase activity and the equilibrium asym- 
metric distribution of exogenously added synthetic 
phospholipids after storage of RBC in CPD or PAG- 
GSS. These defects were attributed largely to severe 
depletion of ATP. In the present study, erythrocyte 
ATP levels did not decline below 0.2 mM in any of 
Table 3 
In vitro characteristics of RBCs after storage in various media 
Adsol ® EAS 25 a EAS 44 b,c EAS 45 b,c 
MCV d (fL) 
lh 
84 days 
ATP ( /xmol /g  Hb) 
Vesicle analyses (84 days) 
Cholesterol ( /xmol /mL)  
Phospholipid ( /xmol /mL)  
Total lipid ( /xmol /mL)  
Total protein (mg/mL)  
90.4 _+ 3.8 114.5 _+ 3.3 112.5 _+ 4.5 101.7 _+ 3.4 
87.5 + 3.0 99.9 4-_ 4. l 95.3 _+ 2.7 95.1 ± 6.7 
1.25 + 0.30 1.71 _+ 0.29 1.64 _+ 0.13 2.10 _+ 0.29 
0.23 4- 0.07 0.09 _+ 0.04 0.08 + 0.03 0.08 ± 0.04 
0.34 4- 0.18 0.13 4- 0.05 0.16 + 0.10 0.14 + 0.07 
0.58 0.22 0.24 0.22 
0.97 0.35 0.3 0.4 
Band 3.0 content e + + + + + + + 
Band 4.1 content e + + + + + + + 
GSH (mg/mL;  84 days) f 0.39 _+ 0.05 0.38 4- 0.05 0.45 4- 0.04 0.53 4- 0.07 
n= 14;bn=5;  _+S.D. 
Dumaswala et al. [36]. 
o Mean Cell Volume. 
e Vesicular band 3 and band 4.1 were detected by immunoblotting and quantitated by densitometric scanning [35] and expressed as 
relative concentrations. 
r Pre-storage value: 0.750 4- 0.076 mg/mL.  
Total lipid = Cholesterol plus Phospholipid. 
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the media, the minimal level of ATP required for 
translocase activity [36,59], yet a 50% reduction in 
transport activity was observed. The equilibrium 
transmembrane distribution of exogenously added PS 
decreased only slightly in both our study (1-9% 
decrease) and that of Geldwerth et al. [58] (17% 
decrease). The greater perturbation of equilibrium 
distribution observed by Geldwerth et al. can be 
attributed to a higher loss of ATP [58]. Though no 
substantial loss of endogenous lipid asymmetry was 
found by Geldwerth et al. [58], a minor amount of 
redistribution of PC and PE occurred within 60 h and 
was attributed in part to oxidative damage of the 
cytoskeleton during storage. In the present study, a 
much greater loss of endogenous PE asymmetry is 
observed. These differences are likely the result of 
different storage conditions. The medium used by 
Geldwerth et al. contained 16 mM sodium phosphate 
in addition to adenine, guanine, sorbitol, glucose and 
sodium chloride. Both media used in the present 
study (Adsol and EAS 25) did not contain phosphate, 
guanine or sorbitol. Since a loss of PE asymmetry 
was observed in Adsol but not in EAS 25, the 
protective effect could be attributed to glycerol 
and/or  hypotonicity. 
Recently, we have shown [36] that RBC phospho- 
lipid asymmetry was also protected in a hypotonic 
additive medium containing glutamine plus phos- 
phate (Pi) (EAS 45), compared to a glutamine-con- 
taining hypotonic medium (EAS 44) or the isoosmo- 
lar Adsol ®. Specifically, a loss of PE asymmetry was 
observed in the latter media. PE contains a higher 
amount of polyunsaturated fatty acids compared with 
other phospholipids and is therefore, more susceptible 
to oxidative damage [60,61]. It is possible that stor- 
age in Adsol ® or in a medium containing lutamine 
alone does not afford adequate protection against 
lipid peroxidation. The resulting oxidative damage 
may induce the flipping of oxidized PE to the outer 
leaflet either spontaneously or through selective 
transport of PE by a lipid scramblase activity, similar 
to the Ca2+-dependent scramblase [15,16,36,51,62]. 
We reasoned that glutamate, generated by 
phosphate-dependent glu aminase activity in EAS 45, 
provides an adequate concentration of glutathione 
precursors and results in the better maintenance of 
reduced glutathione, which is required for the protec- 
tion of membrane constituents from oxidative dam- 
age. Indeed, a comparison of all the hypotonic media 
revealed that even after 84 days of storage, RBCs 
stored in the glutamine plus Pi-containing hypotonic 
medium (EAS 45) could maintain higher (25%) GSH 
levels (Table 3). A paradoxical finding in the present 
study is that despite a similar decline in GSH levels 
in glycerol-containing hypotonic additive or Adsol ®, 
aminophospholipid asymmetry was better maintained 
in EAS 25. These data suggest hat EAS 25 may 
prompt alternate protective mechanisms for preserv- 
ing RBC membrane phospholipid asymmetry, per- 
haps through changes in the bulk physical properties 
of the membrane due to the presence of glycerol. 
In an earlier study [35], we demonstrated that the 
microviscosity of the RBC membrane, an indicator of 
lipid packing, was less affected in EAS 25 than in 
Adsol ®. Bruckdorfer et al. [63] have postulated that 
the beneficial effects of glycerol hydroxyl moieties is 
due to strengthening the association between choles- 
terol and other membrane constituents and in the 
regulation of membrane permeability. More recently, 
Benaim et al. [64] demonstrated that glycerol concen- 
trations less than 5% stimulate the RBC Ca2+-ATPase, 
activate Ca2+-efflux, inhibit Ca2+-dependent pro- 
teases, and better maintain membrane integrity. We 
observed significant increases in intra- and extra-cel- 
lular free amino acid concentrations, indicative of 
enhanced proteolysis, when erythrocytes were stored 
in Adsol ® compared to EAS 25 (data not shown). 
These results are also consistent with our previous 
observation [35] that compared to Adsol®, storage of 
RBCs in EAS 25 diminished microvesiculation, as
measured by loss of bands 3 and 4.1. Recently, Peters 
et al. [65] have shown that band 3 is required for 
membrane stability and to prevent surface loss in the 
form of vesicles. Decreased loss of bands 3 and 4.1 
in glycerol-containing additive solutions may con- 
tribute to the preservation of membrane integrity and 
aminophospholipid asymmetry [11-14]. 
Stretching of the RBC membrane in hypotonic 
media has also been implicated in preventing vesicu- 
lation [66]. The addition of glycerol to the hypotonic 
medium can synergize this effect by intercalating into 
the inner leaflet to prevent echinocytosis and ulti- 
mately vesiculation [67]. Hypotonicity mediated stress 
can also stimulate non-protein-mediated mechanisms 
for lipid transport which may contribute to the main- 
tenance of lipid asymmetry [68,69]. 
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Comparison of a variety of hypotonic media indi- 
cates that though they all induce swelling and de- 
crease vesiculation to the same extent, specific addi- 
tives appear to dictate the biochemical and physical 
parameters of the stored cells, such as ATP and GSH 
levels and phospholipid asymmetry (Table 3). How 
these differences translate into improved in vitro and 
posttransfusion in vivo survival warrants further in- 
vestigation and will be subject of future studies. 
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